Polynomial equations have long served as a cornerstone of mathematical analysis, offering a framework to understand functions, curves, and dynamic systems. In recent years, the study of these ...
A total of 23 studies from 11 registries in eight countries spanning Europe, North America, and Oceania were identified and included in the review. Most studies were retrospective in nature and ...
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer Multicenter prospective ...
After 5 years, Kisqali® plus endocrine therapy consistently shows significant and clinically meaningful benefit in invasive disease-free survival1 Kisqali remains the only CDK4/6 inhibitor ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company applying innovative diagnostics to transform disease management and improve patient outcomes, today announced ...
Please provide your email address to receive an email when new articles are posted on . Microarray-trained models, which include molecular data, better predicted the recurrence of colorectal cancer ...
More specifically, a solution to the recurrence relation is a value that satisfies "if each child call terminates with probability t, the parent call terminates with probability t" but a solution to ...
‒ Poster for GP2 Phase IIb clinical trial final efficacy analysis was presented during the 2020 San Antonio Breast Cancer Symposium (SABCS) today ‒ Phase IIb clinical trial was a prospective, ...
Breast cancer: New data on cohort with recurrence score 26-100 shows 93% cancer-free rate at 5 years
In the prospective TAILORx trial, 93% of women with hormone-sensitive, HER2-negative, axillary node-negative breast cancer and a high Recurrence Score 26-100 were estimated to be cancer-free at five ...
Forty-three percent of trials did not include data on post-recurrence treatment. Researchers identified a lack of data on post-recurrence treatment in trials supporting recent approvals of ...
ST. LOUIS – A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback